GSK plc (GSK)
NYSE: GSK · Pharmaceutical Preparations · London · filing with the SEC since 2001
Who owns GSK plc
As filed with the SECHolders of 5% or more
2
Blackrock, Inc. holds 8.9% of Common Stock, as its SCHEDULE 13G/A filed Mar 7, 2025 says.
Directors and officers
0
report now, of 0 people on the record since . Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Mar 7, 2025 · Common Stock
Fmr LLC
SCHEDULE 13G · filed May 6, 2026 · COMMON STOCK
Dodge & Cox
SCHEDULE 13G/A · filed Aug 13, 2026 · Ordinary Shares and American Depositary Shares · reported falling below 5%
What GSK reports owning in othersstakes of 5% or more, and other ties
Spero Therapeutics, Inc. SPRO
SCHEDULE 13D/A · filed Mar 28, 2025 · Common Stock, Par Value $0.001
CureVac N.V.
SCHEDULE 13D/A · filed Dec 5, 2025 · Common Shares, par value (euro) 0.12 per share · reported falling below 5%
Other ties the annual report names
Overseas
An entity · subsidiary · owns, named in the 20-F filed Mar 6, 2026
ViiV Health Care
A company bought · acquisition · owns, named in the 20-F filed Mar 6, 2026
Its Form 13F-HR for Jun 30, 2026 lists 13 holdings. The record carries no value for them.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.